BIOMAT Database Logo BIOMAT Database Logo

Human mutations affecting the low density lipoprotein pathway. 1979

M S Brown, and J L Goldstein

UI MeSH Term Description Entries
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011955 Receptors, Drug Proteins that bind specific drugs with high affinity and trigger intracellular changes influencing the behavior of cells. Drug receptors are generally thought to be receptors for some endogenous substance not otherwise specified. Drug Receptors,Drug Receptor,Receptor, Drug
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes
D006720 Homozygote An individual in which both alleles at a given locus are identical. Homozygotes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006903 Hydroxymethylglutaryl CoA Reductases Enzymes that catalyze the reversible reduction of alpha-carboxyl group of 3-hydroxy-3-methylglutaryl-coenzyme A to yield MEVALONIC ACID. HMG CoA Reductases,3-Hydroxy-3-methylglutaryl CoA Reductase,HMG CoA Reductase,Hydroxymethylglutaryl CoA Reductase,3 Hydroxy 3 methylglutaryl CoA Reductase,CoA Reductase, 3-Hydroxy-3-methylglutaryl,Reductase, 3-Hydroxy-3-methylglutaryl CoA
D006937 Hypercholesterolemia A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population. Hypercholesteremia,Elevated Cholesterol,High Cholesterol Levels,Cholesterol Level, High,Cholesterol Levels, High,Cholesterol, Elevated,Cholesterols, Elevated,Elevated Cholesterols,High Cholesterol Level,Hypercholesteremias,Hypercholesterolemias,Level, High Cholesterol,Levels, High Cholesterol

Related Publications

M S Brown, and J L Goldstein
Mutations affecting human lipoprotein lipase gene.
June 1996, Zeitschrift fur Gastroenterologie,
M S Brown, and J L Goldstein
Genetic mutations affecting human lipoprotein metabolism.
January 1985, Advances in human genetics,
M S Brown, and J L Goldstein
Update on low density lipoprotein receptor mutations.
April 1998, Current opinion in lipidology,
M S Brown, and J L Goldstein
PCSK9 gene mutations and low-density lipoprotein cholesterol.
April 2014, Clinica chimica acta; international journal of clinical chemistry,
M S Brown, and J L Goldstein
On the metabolic conversion of human plasma very low density lipoprotein to low density lipoprotein.
December 1973, Biochimica et biophysica acta,
M S Brown, and J L Goldstein
Pharmacologic modulation of the low density lipoprotein receptor pathway.
January 1988, Progress in clinical and biological research,
M S Brown, and J L Goldstein
Preparation of drug-low density lipoprotein complexes for delivery of antitumoral drugs via the low density lipoprotein pathway.
August 1987, Cancer research,
M S Brown, and J L Goldstein
Activated human monocytes oxidize low-density lipoprotein by a lipoxygenase-dependent pathway.
July 1990, Journal of immunology (Baltimore, Md. : 1950),
M S Brown, and J L Goldstein
Silent exonic mutations in the low-density lipoprotein receptor gene that cause familial hypercholesterolemia by affecting mRNA splicing.
June 2008, Clinical genetics,
M S Brown, and J L Goldstein
Low-density lipoprotein receptor--its structure, function, and mutations.
February 2004, Seminars in vascular medicine,
Copied contents to your clipboard!